Trial Profile
Phase II Study of YM060 - Double-blind, Parallel-group Comparative Study in Patients (Female) With Diarrhea-predominant Irritable Bowel Syndrome.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary)
- Indications Irritable bowel syndrome
- Focus Therapeutic Use
- 14 Nov 2011 Actual end date (Oct 2011) added as reported by ClinicalTrials.gov.
- 14 Nov 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 11 Apr 2011 Planned End Date changed from 1 May 2011 to 1 May 2012 as reported by ClinicalTrials.gov.